Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test sale cost 8000 AED
Genome Signature HRD Test sale cost 54000 AED Genome Signature HRD Test Cost 72,000 د.إ Original price was: 72,000 د.إ.54,000 د.إCurrent price is: 54,000 د.إ.
Bone Marrow Failure Syndrome Test sale cost 7200 AED Bone Marrow Failure Syndrome Test Cost 9,600 د.إ Original price was: 9,600 د.إ.7,200 د.إCurrent price is: 7,200 د.إ.
Sale!

Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test Cost

Original price was: 13,000 د.إ.Current price is: 8,000 د.إ.

-38%

The Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test is a comprehensive diagnostic tool designed to identify genetic mutations and markers associated with lung cancer. This advanced panel test targets specific genes such as EGFR, BRAF, ALK, ROS, MET, and the protein PD-L1, which are critical in the development, progression, and treatment response of lung cancer. By analyzing these genetic components, the test aids in the personalization of treatment plans, allowing for targeted therapies that can significantly improve patient outcomes.

Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, this test represents a significant advancement in the field of oncology. The cost of the Lung Cancer Panel 8 Test is 8000 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed. By providing detailed insights into the genetic underpinnings of an individual’s lung cancer, the test supports more informed decision-making in treatment planning, potentially leading to more effective management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test

Are you concerned about lung cancer? DNA Labs UAE offers the Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test to help diagnose and guide treatment decisions for this disease.

Test Details

The Lung Cancer Panel 8 is a genetic test that analyzes eight genes commonly associated with lung cancer. These genes include:

  1. EGFR (Epidermal Growth Factor Receptor): A protein that plays a role in cell growth and division. Mutations in the EGFR gene are commonly found in non-small cell lung cancer (NSCLC) and can be targeted by certain medications.
  2. BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase): A gene that codes for a protein involved in cell signaling. Mutations in BRAF are found in a small percentage of NSCLC cases and can also be targeted by certain medications.
  3. ALK (Anaplastic Lymphoma Kinase): A gene that codes for a protein involved in cell growth and division. ALK mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.
  4. ROS1 (ROS Proto-Oncogene 1, Receptor Tyrosine Kinase): A gene that codes for a protein involved in cell signaling. ROS1 mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.
  5. MET (MET Proto-Oncogene, Receptor Tyrosine Kinase): A gene that codes for a protein involved in cell growth and division. MET mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.
  6. PDL1 (Programmed Death-Ligand 1): A protein that helps regulate the immune system. PDL1 expression levels can be used to predict response to certain immunotherapy treatments.
  7. KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog): A gene that codes for a protein involved in cell signaling. KRAS mutations are found in a significant percentage of NSCLC cases but currently have no targeted therapies.
  8. TP53 (Tumor Protein P53): A gene that codes for a protein involved in cell cycle regulation and DNA repair. TP53 mutations are found in a significant percentage of NSCLC cases but currently have no targeted therapies.

The Lung Cancer Panel 8 test can help guide treatment decisions by identifying specific genetic mutations that may be targeted by certain medications or immunotherapies. It can also help predict response to treatment and overall prognosis.

Test Cost and Sample Condition

The cost of the Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test at DNA Labs UAE is AED 8000.0. The test requires paraffin embedded tissue blocks as the sample condition.

Report Delivery and Method

The report for the Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test will be delivered within 5-7 days. The test utilizes FISH, Sanger Sequencing, and IHC methods for analysis.

Pre Test Information

A Doctor’s prescription is required for the Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test. However, the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Doctor and Test Department

The Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test is performed by an Oncology specialist and falls under the Genetics test department.

Test Name Lung Cancer Panel 8 EGFRBRAFALKROSMETPDL1 Test
Components Paraffin embedded tissue blocks
Price 8000.0 AED
Sample Condition Tumor tissue
Report Delivery 5-7 days
Method FISH,Sanger Sequencing,IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Lung Cancer Panel 8 (EGFR,BRAF,ALK,ROS,MET,PDL1) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Lung Cancer Panel 8 is a genetic test that analyzes eight genes commonly associated with lung cancer. These genes include:

1. EGFR (Epidermal Growth Factor Receptor): A protein that plays a role in cell growth and division. Mutations in the EGFR gene are commonly found in non-small cell lung cancer (NSCLC) and can be targeted by certain medications.

2. BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase): A gene that codes for a protein involved in cell signaling. Mutations in BRAF are found in a small percentage of NSCLC cases and can also be targeted by certain medications.

3. ALK (Anaplastic Lymphoma Kinase): A gene that codes for a protein involved in cell growth and division. ALK mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.

4. ROS1 (ROS Proto-Oncogene 1, Receptor Tyrosine Kinase): A gene that codes for a protein involved in cell signaling. ROS1 mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.

5. MET (MET Proto-Oncogene, Receptor Tyrosine Kinase): A gene that codes for a protein involved in cell growth and division. MET mutations are found in a small percentage of NSCLC cases and can be targeted by certain medications.

6. PDL1 (Programmed Death-Ligand 1): A protein that helps regulate the immune system. PDL1 expression levels can be used to predict response to certain immunotherapy treatments.

7. KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog): A gene that codes for a protein involved in cell signaling. KRAS mutations are found in a significant percentage of NSCLC cases but currently have no targeted therapies.

8. TP53 (Tumor Protein P53): A gene that codes for a protein involved in cell cycle regulation and DNA repair. TP53 mutations are found in a significant percentage of NSCLC cases but currently have no targeted therapies.

The Lung Cancer Panel 8 test can help guide treatment decisions by identifying specific genetic mutations that may be targeted by certain medications or immunotherapies. It can also help predict response to treatment and overall prognosis.

SKU: TEST-694 Category:

Related products